130 related articles for article (PubMed ID: 9252199)
1. Nitric oxide enhancement of melphalan-induced cytotoxicity.
Cook JA; Krishna MC; Pacelli R; DeGraff W; Liebmann J; Mitchell JB; Russo A; Wink DA
Br J Cancer; 1997; 76(3):325-34. PubMed ID: 9252199
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin.
Wink DA; Cook JA; Christodoulou D; Krishna MC; Pacelli R; Kim S; DeGraff W; Gamson J; Vodovotz Y; Russo A; Mitchell JB
Nitric Oxide; 1997 Feb; 1(1):88-94. PubMed ID: 9701048
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells.
Ongaro A; Pellati A; De Mattei M; De Terlizzi F; Rossi CR; Campana LG
Anticancer Drugs; 2015 Mar; 26(3):284-92. PubMed ID: 25514113
[TBL] [Abstract][Full Text] [Related]
5. Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts.
Evig CB; Kelley EE; Weydert CJ; Chu Y; Buettner GR; Burns CP
Nitric Oxide; 2004 May; 10(3):119-29. PubMed ID: 15158691
[TBL] [Abstract][Full Text] [Related]
6. Misonidazole hypoxic cytotoxicity and chemosensitization in two cell lines with different intracellular glutathione levels.
DeGraff WG; Russo A; Friedman N; Mitchell JB
Eur J Cancer; 1990 Jan; 26(1):17-20. PubMed ID: 2138473
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
8. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO.
Wink DA; Feelisch M; Fukuto J; Chistodoulou D; Jourd'heuil D; Grisham MB; Vodovotz Y; Cook JA; Krishna M; DeGraff WG; Kim S; Gamson J; Mitchell JB
Arch Biochem Biophys; 1998 Mar; 351(1):66-74. PubMed ID: 9501920
[TBL] [Abstract][Full Text] [Related]
9. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
10. Sensitization effect of L-2-oxothiazolidine-4-carboxylate on tumor cells to melphalan and the role of 5-oxo-L-prolinase in glutathione modulation in tumor cells.
Chen X; Batist G
Biochem Pharmacol; 1998 Sep; 56(6):743-9. PubMed ID: 9751079
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of the mycotoxin patulin in cultured Chinese hamster V79 cells, and its modulation by intracellular glutathione.
Schumacher DM; Metzler M; Lehmann L
Arch Toxicol; 2005 Feb; 79(2):110-21. PubMed ID: 15536543
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake.
Skarsgard LD; Skwarchuk MW; Vinczan A; Kristl J; Chaplin DJ
Anticancer Res; 1995; 15(1):219-23. PubMed ID: 7733636
[TBL] [Abstract][Full Text] [Related]
13. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity.
Hirota H; Gosky D; Berger NA; Chatterjee S
Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894
[TBL] [Abstract][Full Text] [Related]
14. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection.
Wink DA; Cook JA; Pacelli R; DeGraff W; Gamson J; Liebmann J; Krishna MC; Mitchell JB
Arch Biochem Biophys; 1996 Jul; 331(2):241-8. PubMed ID: 8660704
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
[TBL] [Abstract][Full Text] [Related]
17. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.
Barnouin K; Leier I; Jedlitschky G; Pourtier-Manzanedo A; König J; Lehmann WD; Keppler D
Br J Cancer; 1998; 77(2):201-9. PubMed ID: 9460989
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to the cytotoxicity of melphalan by ethacrynic acid and hyperthermia in drug-sensitive and multidrug-resistant Chinese hamster ovary cells.
Turcotte S; Averill-Bates DA
Radiat Res; 2001 Sep; 156(3):272-82. PubMed ID: 11500136
[TBL] [Abstract][Full Text] [Related]
20. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
